GUProstate cancer Episode 22: PSMA-based radioligand therapy: a new treatment modality for patients with metastatic castration-resistant prostate cancer 1 July 2024
GUProstate cancer Episode 21: Neoadjuvant degarelix with or without apalutamide prior to surgery for high-risk prostate cancer: results of the phase II ARNEO trial 24 June 2024
GUProstate cancer Episode 20: Dose-escalated radiotherapy with or without short-term ADT for patients with intermediate-risk prostate cancer 17 June 2024
GUProstate cancer Episode 19: Relugolix as hormone therapy for men with advanced prostate cancer: results from the HERO trial 10 June 2024
GUProstate cancer Episode 18: PSA-based screening for prostate cancer: 21-year follow-up of the Rotterdam section of the ERSPC study 3 June 2024
GUProstate cancer Episode 17: Prostate irradiation for men with newly-diagnosed, metastatic castration-sensitive prostate cancer: new insights from PEACE-1 27 May 2024
GUProstate cancer Episode 16: Active surveillance solidified as standard of care for patients with low-risk, localized prostate cancer: 15-year update from ProtecT 20 May 2024
GUProstate cancer Episode 15: Adding stereotactic radiotherapy to abiraterone acetate significantly delays disease progression in oligometastatic CRPC patients: the ARTO trial 13 May 2024
GUProstate cancer Episode 14: Improved clinical outcomes with the combination of olaparib and abiraterone-acetate in the 1st line treatment of metastatic CRPC 6 May 2024
GUProstate cancer Episode 13: Enzalutamide for biochemically recurrent prostate cancer: reflections on the EMBARK trial 29 April 2024
